PRO DEX INC (PDEX)
Health Care · Medical instruments & supplies · NASDAQ
Pro-Dex designs and manufactures precision surgical handpieces and medical devices, while expanding into aerospace machining through its recent acquisition of APM.
What PRO DEX INC does
Pro-Dex specializes in the design, development, and manufacture of autoclavable, battery-powered, and electric multi-function surgical drivers and shavers for the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also provides engineering and regulatory consulting services and manufactures precision machined parts for the aerospace and defense industries through its Advanced Precision Machining (APM) subsidiary. Its products are primarily sold to medical device OEMs and distributors.
Recent developments
In February 2026, the company acquired Advanced Precision Machining (APM), a manufacturer of sub-assemblies and parts for medical, aerospace, and defense applications. In the fourth quarter of fiscal 2026, the company reported strong sales growth driven by the ramp-up of a next-generation orthopedic handpiece for its largest customer.
From PRO DEX INC's filing of 2026-09-03.
Themes: surgical devices, medical device manufacturing, aerospace and defense manufacturing, precision machining, contract manufacturing
Fundamentals
- Price$62.21 as of 2026-10-08 close
- Market cap$199M as of 2026-09-02 (share count; price 2026-10-08)
- 1-year return+79.1% 2025-10-08 close $34.74 → 2026-10-08 close $62.21
- P/E17.16 as of 2026-10-08
- Net margin+17.6% FY2026, SEC XBRL
- Gross margin+31.4% FY2026, SEC XBRL
- ROE+28.7% FY2026, SEC XBRL
- Debt / equity0.41 as of 2026-09-02
- Revenue growth (YoY)+16.4% as of 2026-09-02
- Revenue CAGR (3y)+18.9% SEC XBRL
- Beta0.70 as of 2026-09-02
- Last reported earnings2026-09-03 SEC EDGAR Form 8-K (Item 2.02)
How PDEX compares in its sector
- price-to-earnings ratiobottom 25% 185 covered Health Care peers, as of 2026-10-08
- net profit margintop 25% 430 covered Health Care peers, as of 2026-09-02
- operating margintop 25% 417 covered Health Care peers, as of 2026-09-02
- gross marginbottom 25% 189 covered Health Care peers, as of 2026-09-02
- return on equitytop 10% 510 covered Health Care peers, as of 2026-09-02
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 494 covered Health Care peers, as of FY2026
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How PRO DEX INC looks technically
PRO DEX INC (PDEX) is trading 13.8% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 165 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 17, below the 25 that marks a real trend), though sellers have been pushing harder than buyers lately — pressure, not a trend. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 40, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 7 trading days ago (its momentum flipped negative). It made a new 20-day low about 21 trading days ago. It is 19.2% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 13.8% above its 200-day average, the long-term trend line — a longer-term uptrend | +13.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $66.23 | $66.23 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $54.69 | $54.69 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 13 calendar days ago — the swings before that are what the structure reading is measured on | 13 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes above 74.2. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible downward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 165 trading days ago — a "golden cross", a bullish long-term signal | 165 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 17, below the 25 that marks a real trend), though sellers have been pushing harder than buyers lately — pressure, not a trend | 16.7 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 40, neither overbought (above 70) nor oversold (below 30) | 39.8 |
|---|---|---|
| Position in its 14-day range | it is trading near the bottom of its 14-day range ($60.54 to $74.20) — its "stochastic" reading is 12 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 12.2 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 7 trading days ago (its momentum flipped negative) | 7 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $77.00 | $77.00 |
|---|---|---|
| From the 52-week high | it is 19.2% below its 52-week high (its highest price of the past year) | -19.2% |
| Above the 52-week low | it is 165.1% above its 52-week low (its lowest price of the past year) | +165.1% |
| Below the 52-week high | it is 19.2% below its highest point of the past year | 19.2% |
| Since a 20-day breakout | it made a new 20-day low about 21 trading days ago | 21 sessions |
| Since a 55-day breakout | it made a new 55-day high about 24 trading days ago | 24 sessions |
| All-time high | its highest closing price on record is $77.00 (set on 2026-09-04) | $77.00 |
| Given back of the 52-week move | over the past year its closes ranged ($23.91 to $73.41), and it has given back roughly a quarter of its rise from last year’s low — 23% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $41.23 to $42.82. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 22.6% |
| From the all-time high | it is 19.2% below its all-time high | -19.2% |
| Nearest price level | it is trading 0.8% above a support level at $61.68 — a price it turned at twice since 2026-05-08, most recently on 2026-08-18. Since 2024-10-08 it has 16 such levels below the current price and 1 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.8% |
| All-time low | its lowest closing price on record is $0.8105 (set on 2009-03-03) | $0.8105 |
| Above the all-time low | it is 7575.4% above its all-time low | +7,575% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 60th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $3.46 between its high and its low — about 5.6% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $3.46 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $60.91 and $75.81 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $60.91 – $68.36 – $75.81 |
| Typical daily range (% of price) | its price moves about 5.6% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 5.6% |
| Stretch from the 200-day average | it is trading 2.2 daily ranges above its 200-day average price (13.8% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 2.2 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.65× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
2
| Since a doji | 2 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 2 sessions ago |
|---|---|---|
| Since a bearish engulfing | 7 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 7 sessions ago |
Price gaps
2
| Gap at the open | it opened on 2026-10-08 0.6% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.6% |
|---|---|---|
| Gap filled | a 12.6% gap up opened on 2026-09-04 has been "filled" 21 sessions ago — price traded back through the level the gap left behind, and it took 2 sessions to close | 21 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 3 sessions in a row, a -4.89% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 3 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 7.4 percentage points (the stock lost 6.3% while the market gained 1.0%) | -7.4% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 0.3 percentage points (the stock gained 4.1% while the market gained 3.8%) | +0.3% |
| vs market, 6 months | over the past 6 months this stock beat the market by 10.7 percentage points (the stock gained 28.2% while the market gained 17.5%) | +10.7% |
| vs market, 12 months | over the past 12 months this stock beat the market by 64.1 percentage points (the stock gained 79.1% while the market gained 15.0%) | +64.1% |
Signal agreement
2
| Bullish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, outperforming the market over 6 months, near the bottom of its 14-day range (oversold) — these describe past price behaviour, not a forecast | 4 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: MACD momentum is negative — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is moderate, spanning 2.4% of the share price. | 0.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 5% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $59.43 — a volume-weighted average of daily closes over 191 sessions, not a true tick-by-tick VWAP. | +4.7% |
|---|---|---|
| Vs the average paid since it last reported | the price is 8% below the average price paid since it last reported on 2026-09-03 (its 10-K), so the typical buyer over that stretch is under water. That average is $67.76 — a volume-weighted average of daily closes over 25 sessions, not a true tick-by-tick VWAP. | -8.2% |
Rising wedge, bearish — broke down · entry $63.32 · 90 sessions in
Price levels it has turned at before
PDEX last closed at $62.21 on 2026-10-08. Since 2024-10-08 it has turned at 16 prices below its last close and 1 above; the 3 nearest below and the nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $61.68 | Support | 0.8% below the last close | turned there twice · 2026-05-08 to 2026-08-18 |
| $59.33 | Support | 4.6% below the last close | turned there twice · 2025-01-06 to 2026-06-11 |
| $55.25 | Support | 11.2% below the last close | turned there three times · 2024-12-06 to 2026-06-29 |
| $69.21 | Resistance | 11.3% above the last close | turned there three times · 2026-06-02 to 2026-08-17 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes above $74.20.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $43.52 and $55.24 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close above $74.20.
This reading has stood for 5 trading days, since 2026-10-02.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · trendless / choppy (low ADX) · beating the market · At the bottom of its 14-day range (stochastic below 20) · Under water since its last earnings report (below the anchored VWAP) · Trading inside the Ichimoku cloud | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$74.00 range $74.00 – $74.00
Analyst estimates, as of 2026-10-04. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for PDEX
- Consensus EPS estimate$0.67 next reporting period, as of 2026-10-04
- Readings revised upward0% of 3 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["High customer concentration, with a significant majority of revenue derived from a small number of customers.","Volatility in net income due to gains/losses on marketable equity investments.","Dependence on successful execution of development/supply agreements and rapid technological evolution in the medical device sector."]
What changed in the latest 10-Q
AI-assisted comparison of PDEX's 10-Q filed 2026-04-30 against the prior one filed 2026-01-29.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-04-30) specifies comparison periods as 'three-month and nine-month periods ended March 31, 2026 and 2025' versus older filing's 'three-month and six-month periods ended December 31, 2025 and 2024'
- Newer filing adds risk factor: 'our ability to integrate and effectively operate Advanced Precision Machining, LLC ("APM")'
- Newer filing adds risk factor: 'the impact of tariffs on the cost of our raw materials and purchased components'
- Newer filing states: 'During the third quarter of fiscal 2026, we completed the acquisition of APM, one of our significant suppliers'
- Newer filing mentions APM's location: 'a second machine shop located in Costa Mesa, California'
- Newer filing states APM provides 'machining to other customers primarily in the defense and aerospace industries'
- Newer filing lists two Internet addresses: 'www.pro-dex.com and www.advanced-precision.com'
- Newer filing adds reference to 'www.sec.gov/edgar/searchedgar/companysearch.html' for SEC filings
- Removed:
- Older filing (2026-01-29) included risk factor: 'our ability to optimize our operations at our Franklin facility'
- Older filing stated: 'Additionally, we provide engineering, quality, and regulatory consulting services to our customers'
- Older filing stated rotary air motors 'comprise a de minimis portion of our business'
- Older filing stated: 'We are actively pursuing the acquisition of one of our significant suppliers to help meet the increased demand'
- Older filing included product discussion: 'our latest Pro-Dex branded product, the Helios driver for CMF applications, featuring our adaptive torque-limiting software, is expected to be released for production later this fiscal year'
- Older filing contained statement: 'While we have had interest in this product, there is no guarantee that our existing customers or new customers will purchase this new driver'
- Older filing listed only 'www.pro-dex.com' as Internet address (singular)
- Reworded:
- Older filing stated 'which appeal to our customers' changed to 'which appeal to our customers' in newer (minor punctuation change from semicolon to period structure)
- Newer filing: 'precision machined parts and assemblies for the aerospace and defense industries through our APM subsidiary' - this is expanded detail replacing older filing's mention of rotary air motors as de minimis
- Older filing reference to 'three and six months ended December 31, 2025' changed to 'three and nine months ended March 31, 2026' in Critical Accounting Estimates section
- Notes:
- Newer filing text appears truncated at end ('Our patented adaptive torque-limiting softw'), preventing full comparison of final sections
- Older filing text also appears truncated ('In November 2020, we purchased an approximate 25,000 square foot indust'), preventing full comparison
- The filings cover different fiscal periods (Q2 FY2026 vs Q3 FY2026), which naturally accounts for some content changes regarding business developments
Risk Factors
- Added:
- Added goodwill of $6,525 thousand as of March 31, 2026 in non-current assets (newer filing, filed 2026-04-30)
- Added 'Purchase of APM, net of cash acquired' investing activity of $6,495 thousand for nine months ended March 31, 2026 (newer filing, filed 2026-04-30)
- Added 'Promissory note issued in conjunction with APM acquisition' non-cash activity of $2,000 thousand (newer filing, filed 2026-04-30)
- Added 'Amortization of loan fees, net' of $8 thousand in operating activities adjustments for nine months ended March 31, 2026 (newer filing, filed 2026-04-30)
- Removed:
- Removed disclosure of allowance for expected credit losses in accounts receivable description (was shown in older filing, absent in newer filing)
- Reworded:
- Balance sheet header changed from 'PRO-DEX, INC. AND SUBSIDIARY' (older filing, filed 2026-01-29) to 'PRO-DEX, INC. AND SUBSIDIARIES' (newer filing, filed 2026-04-30)
- Income statement header changed from 'STATEMENTS OF OPERATIONS' (older filing, filed 2026-01-29) to 'INCOME STATEMENTS' (newer filing, filed 2026-04-30)
- Common stock description changed from 'Common stock; no par value' (older filing, filed 2026-01-29) to 'Common shares; no par value' (newer filing, filed 2026-04-30)
- Line item changed from 'Gain (loss) on marketable equity investments, net' in older filing (filed 2026-01-29) to 'Gain on equity investments, net' in newer filing (filed 2026-04-30)
- Line item changed from 'Non-cash lease recovery' in older filing (filed 2026-01-29) to 'Non-cash straight-line lease amortization' in newer filing (filed 2026-04-30)
- Notes:
- The two filings cover different reporting periods: older filing is for six and three months ended December 31, 2025; newer filing is for nine and three months ended March 31, 2026
- Balance sheet comparisons use different prior-year dates (June 30, 2025 in both) but different current period dates (December 31, 2025 vs. March 31, 2026)
- Financial statement figures are not directly comparable due to different fiscal periods covered
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 13 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 30 days · read to 2026-10-040 buys · 2 sells ($45412) — 1 selling insider
- Last 90 days · read to 2026-10-040 buys · 13 sells ($1M) — 2 selling insiders
- Last 180 days · read to 2026-10-040 buys · 19 sells ($2M) — 2 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-09-11. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about PDEX's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
3 institutional 13F filers reported holding PDEX as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 3
- Reported shares held 184,744
- Reported value $10,816,762
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 2 increased, 1 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about PDEX's institutional holders → See what each manager we track holds →
Short interest (FINRA)
PDEX had 209,908 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
PDEX had 6.55% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 2.29 days to cover at the same settlement.
- Reported short interest (shares) 209,908
- Short interest (% of shares outstanding) 6.55%
- Prior settlement (shares) 178,804
- Reported change 17.4%
- Days to cover (reported) 2.29
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Stryker (SYK)
- Medtronic (MDT)
- Zimmer Biomet (ZBH)
- DePuy Synthes (JNJ)
- ConMed (CNMD)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare PDEX vs…
Frequently asked questions
What does PRO DEX INC (PDEX) do?
Pro-Dex specializes in the design, development, and manufacture of autoclavable, battery-powered, and electric multi-function surgical drivers and shavers for the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also provides engineering and regulatory consulting services and manufactures precision machined parts for the aerospace and defense industries through its Advanced Precision Machining (APM) subsidiary.
What sector is PRO DEX INC (PDEX) in?
PRO DEX INC (PDEX) is classified in the Health Care sector. Its industry is Medical instruments & supplies. It trades on NASDAQ.
Who are PRO DEX INC's (PDEX) competitors?
Notable peers of PRO DEX INC (PDEX) include Stryker, Medtronic, Zimmer Biomet, DePuy Synthes and ConMed. This peer set is informational only — not financial advice.
Is PRO DEX INC (PDEX) overbought or oversold right now?
PRO DEX INC (PDEX) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 40, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on PDEX come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest; prices are market data, as of 2026-09-02; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.